Functional studies are required for a conclusive demonstration that these sequences are indeed active OR genes.
The demonstration that sequences homologous to the core elements (>70% homology) covered approximately 90% of the SD13M region indicated that our method can characterize the repetitive structure of SD13M effectively.
Proposition 4 means (see appendix for a demonstration) that, in (2), the sequence which corresponds to two iterations, may be replaced by (successively k0 d and ks0 markers): Corollary 1: In the summation SΩ, a sequence M c of markers all belonging to " k" types (i.e. non amb) appears as a single element where only the certain transmissions are involved.
Proposition 3 means (see appendix for a demonstration) that, in (2), the sequence: which corresponds to two iterations, may be replaced by: Proposition 4: In the summation SΩ, the elements corresponding to the unknown parental transmission for types k0 d or ks0 markers can be ignored, i.e. they may be bypassed in the iterative system (2).
These data provide the first demonstration that the CCCGGG sequence is a transcriptionally active DNA-binding site for p53.
Further support for the theory that YtfM/N form a TPS system is derived from the demonstration that both possess signal sequences for location to the periplasm.
In this paper, several additional tests are provided, including the demonstration that star phylogenies (in which all sequences stem from a single common ancestor with no branching structure) explain the simulated data but not real sequence data, as does a profile model in which sequences are independently generated from a profile with no phylogenetic structure.
This study provides a compelling demonstration that, in spite of substantial sequence length, there are significant limitations with single-locus phylogenetics.
Here, beyond the demonstration that gene duplicates among species can be quantified with aCGH, we consider the effect of sequence divergence on the ability to detect gene duplicates.
Stafib-1 provides the first demonstration that naturally occurring SH2 domains with more than 90%% sequence identity can be selectively targeted with small organic molecules.
